AUDC vs LTRX

The company exhibits a weak Piotroski F-Score of 4/9, indicating marginal financial health, and lacks an Altman Z-Score, limiting distress risk assessment. While profitability metrics like gross margin and ROE are relatively solid, growth is sluggish and valuation multiples are mixed. The stock trades above the Graham Number of $7.99 but below the intrinsic value estimate of $9.71, suggesting modest undervaluation. However, weak earnings consistency, declining price trends, and low analyst coverage temper optimism.

Lantronix exhibits a stable financial foundation with a Piotroski F-Score of 6/9 and strong liquidity ratios, yet it faces significant operational headwinds. While the balance sheet is healthy with low debt (D/E 0.25) and a high current ratio (2.75), the company is struggling with negative revenue growth (-4.5% YoY) and negative profit margins. The stock has experienced a massive 192% price surge over the last year, which appears disconnected from current fundamental performance, creating a valuation gap. Despite analyst optimism with a target price of $9.12, the lack of top-line growth and bearish insider sentiment warrant a cautious approach.